brand name drugs

Supreme Court Weighs Drugmakers’ ‘Pay for Delay’ Deals

Posted on 03/25/2013 by | General News | Comments

Bulletin Today | Personal HealthBy Jesse J. Holland and Linda A. Johnson of The Associated Press WASHINGTON (AP) — The Supreme Court struggled Monday with whether it should allow federal officials to challenge deals between pharmaceutical corporations and their generic drug competitors that the government says could keep cheaper forms of medicine off the American market for longer periods of time. Justices heard arguments from the Justice Department against what they call “pay-for-delay” deals or “reverse settlements.” Such deals arise when generic companies file …

Drugmakers, Interpol Ramp Up Fight Against Fakes

Posted on 03/12/2013 by | General News | Comments

Bulletin TodayBy Linda A. Johnson, Business Writer, The Associated Press More than two dozen of the world’s largest pharmaceutical companies have agreed to provide funding and other support to Interpol’s battle against counterfeit prescription drugs, the international police agency said Tuesday. Interpol’s newly created Pharmaceutical Crime Program aims to help health agencies, police and customs bureaus in countries around the globe stem the supply of bogus brand-name and generic medicines, as well as identify and dismantle the organized crime rings distributing …

Study: Doctors Give In to Patient Demands for Brand-Name Drugs

Posted on 01/8/2013 by | Health | Comments

Bulletin Today | Personal HealthBy Alvin Tran of Kaiser Health News Doctors are more likely to prescribe brand-name drugs over lower-cost generics when patients request them and when physicians have contacts with drugmakers, a study published in JAMA Internal Medicine Monday shows. The researchers from Massachusetts General Hospital in Boston analyzed data from a survey of 1,891 doctors in 2009 and found that 37 percent of  doctors admitted to sometimes prescribing a brand-name drug at a patient’s request even though a generic version of …

Skyrocketing Drug Prices

Posted on 08/25/2010 by | Archived Contributor | Comments

Personal HealthAARP released a report today that finds that prices of widely used brand name prescription drugs skyrocketed last year – “skyrocketed” meaning climbed more than eight percent (8%) even while general inflation remained negative. The New York Times covered the findings here. The report – called Rx Price Watch – is the first of its kind, looking at the retail price of drugs – that is, the amount that is actually charged to consumers (and/or insurers). The findings of this …